StonvexLoading…
StonvexStonvexStonvexCore line items from AAL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $54.63B | $54.21B | $52.79B | $48.97B |
Operating Income | $1.47B | $2.61B | $3.03B | $1.61B |
Net Income | $111.00M | $846.00M | $822.00M | $127.00M |
EPS (Diluted) | $0.17 | $1.24 | $1.21 | $0.19 |
Total Assets | $61.77B | $61.78B | $63.06B | $64.72B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.06B | $902.00M | $681.00M | $586.00M |
Free Cash Flow OCF − CapEx | $-680.00M | $1.30B | $1.21B | $-373.00M |
Shares Outstanding | 660.30M | 657.57M | 654.27M | 650.64M |